Risk factor modification through weight loss enhanced with pharmacotherapy
- PMID: 11772422
- DOI: 10.1007/s11883-002-0066-7
Risk factor modification through weight loss enhanced with pharmacotherapy
Original report in
-
Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.Am Heart J. 2001 Sep;142(3):489-97. doi: 10.1067/mhj.2001.117510. Am Heart J. 2001. PMID: 11526363 Clinical Trial.